Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eiger BioPharmaceuticals, Inc. | CEO, Director | Stock Option (Right to Buy) | 750K | Jul 3, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EIGR | Eiger BioPharmaceuticals, Inc. | Jul 3, 2023 | 1 | $0 | 4 | Jul 6, 2023 | CEO, Director |
EIGR | Eiger BioPharmaceuticals, Inc. | Jan 31, 2023 | 1 | $0 | 4 | Feb 2, 2023 | Interim CEO, Director |
EIGR | Eiger BioPharmaceuticals, Inc. | Aug 16, 2022 | 1 | -$49K | 4 | Aug 18, 2022 | Director |
EIGR | Eiger BioPharmaceuticals, Inc. | Mar 11, 2022 | 2 | $0 | 4 | Mar 11, 2022 | Director |